Ishii and Shimo3 speculated, on the basis of muscle tension measurements, that increased responsiveness of airway smooth muscle to acetylcholine with lowered temperature may involve the acceleration of Ca2+ release from intracellular storage sites, inhibition of Ca2+ extrusion from the cell, or the inhibition of Ca2+ reuptake by intracellular storage sites. The exact mechanism of low temperature-induced sensitivity to contractile agonists, however, is unclear. Volatile anesthetics are potent bronchodilators and often are used for severe asthmatic patients.* Upper airway smooth muscle in such cases is exposed to cool air during tracheal intubation. The temperature of airway smooth muscle also is decreased during a cardiopulmonary bypass operation and during mild hypothermic the rap^,^,^ and volatile anesthetics sometimes are used for the anesthesia. The decrease in temperature in these situations, therefore, has an effect on the airway smooth muscle tone and might mod@ the inhibitory effects of volatile anesthetics on the muscle tone.
The aim of the current study was to investigate lowtemperature modifications of the inhibitory effects of the volatile anesthetics isoflurane and sevoflurane on canine tracheal smooth muscle tone in vitro by simultaneously measuring muscle tension and intracellular concentration of free Ca2+ ([Ca2'],) and by measuring voltage-dependent Ca2+ channel (VDCC) activity. [CaZ+Ii itself primarily controls the contractile state of the muscle,' and VDCC is important in regulating the [Ca2t]i.s29
Materials and Methods
The protocol for this study was approved by the Sapporo Medical University Ethical Committee on Animal Research. Adult mongrel dogs weighing 10-15 kg were anesthetized with 10 mg/kg intramuscular ketamine and killed by exsanguination. The tracheas were excised quickly, and the epithelium, cartilage, and connective tissue were stripped from the smooth muscle.
Simultaneous Measurement of Muscle Tension and [Caz+Ji
Tissue preparation was performed according to the previously described method.8 Briefly, tracheal smooth muscle strips (1 mm wide and 8 mm long) were pretreated with 5 p~ acetoxymethyl ester of fura-2, an indicator of Ca2+, in a physiologic salt solution containing 0.02% (voVvo1) cremophor EL for 6 or 7 h at room temperature (22-24°C). The fura-2-loaded muscle strip was held in a temperature-controlled (37°C) organ bath, and one end of the muscle strip was connected to a strain gauge transducer. The temperature of the bath solution was monitored continuously using a thermometer (CTM-205; Terumo, Tokyo, Japan). Experiments were performed using a fluorescence spectrometer (CAF-100; Japan Spectroscopic, Tokyo, Japan). Excitation light was passed through a rotating filter wheel (48 Hz) that contained 340-and 380-nm filters. The light emitted from the muscle strip at 500 nm was measured using a photomultiplier. The ratio of the fluorescence resulting from excitation at 340 nm to that at 380 nm (R340/380) was calculated and used as an indicator of [Ca2+Ii.',' Contractions were induced by high-K+ (72.7 mM) and carbachol (I p~) , a potent muscarinic receptor agonist. After the contractions reached a steady state, the temperature of the organ bath was changed from 37°C to 34 or 31°C. In another experiment, the tissues were exposed to a bath solution equilibrated using one of two volatile anesthetics: isoflurane (1.0, 2.0, or 3.0% at the vaporizer) or sevoflurane (1.0, 2.0, or 3.0%), with simultaneous changes in the temperature of the bath solution (34°C or 31°C).
Because there is a possibility that changes in temperatureper se can change the affinity of fura-2 for Ca2+," we confirmed the effect of temperature on R340/380 of the tracheal smooth muscle strips by the use of the skinned fiber technique." The muscle strips (0.1-0.2 mm wide) were superfused for 20 min using a relaxing solution containing 50 Fg/ml saponin and 5 FM acetoxymethyl ester of fura-2. The relaxing solution was made with the following composition using the algorithm of Fabiato and Fabiato:" Mg-ATP: 7.5 mM; EGTA: 4.0 mM; imidazol: 20 mM; dithiothreitol: 1.0 mM; free MgZ+: 1.0 mn; free Ca2+: 1 nM; creatine phosphate: 10 mM; and creatine phosphokinase: 0.1 mg/ml. After incubation with 0.3 PM free Ca2+, the temperature of the organ bath was changed within the range between 37 and 31°C. R340,380, an indicator of [Ca'+Ii, did not change within the temperature range tested with or without 1 p~ carbachol (n = 4, data not shown).
Measurement of Voltage-dependent CaZ

Channel Activity
We used conventional whole cell patch clamp techniques to observe inward Ca2+ currents Oca) through VDCCS.'~ Tracheal smooth muscle tissue was minced and digested for 20 min at 37°C in Ca2+-free Tyrode's solution to which 0.08% (wt/vol) collagenase was added.14 CeUs were dispersed by trituration, filtered through nylon mesh, and centrifuged. The pellet was resuspended in a modified Kraftbriihe solution15 and stored at Micropipettes were pulled from soda lime "hematocrit" tubing (GC-1.5; Narishige, Tokyo, Japan) using a brown-flaming horizontal puller (model P-97; Sutter Instrument, Novato, CA). aminomethane. An aliquot (approximately 0.5 ml) of the cell suspension was placed in a chamber on the stage of an inverted microscope. A micromanipulator was used to position the patch pipette against the membrane of a tracheal smooth muscle cell.
After obtaining a high-resistance seal (> 5 GO), the patch membrane was disrupted by strong negative pressure. Membrane currents were monitored using a CEZ-2400 patch clamp amplifier (Nihon Kohden, Tokyo, Japan), and the amplifier output was low-pass filtered at 2,000 Hz.
Inward Ca2+ currents were elicited by 100-ms depolarizing pulses (-50 to 40 mv> from a holding potential of -80 mV. Leak currents were subtracted, and membrane capacitance and series resistance were compensated. After a stable baseline of peak I, , was obtained at 37"C, the temperature of the bath solution was changed to 31°C. In another experiment, cells were exposed to a bath solution equilibrated using one of two volatile anesthetics, isoflurane (1.0, 2.0, or 3.0%) or sevoflurane (1.0, 2.0, or 3.0%), with simultaneous change in the temperature of the bath solution from 37 to 31°C. Inactivation curves also were determined, using a doublepulse protocol that consisted of a 3-s prepulse to a potential in the range between -80 and 10 mV, followed by a 100-ms depolarization to 10 mV. The peak change in the current was expressed as a fraction of that obtained using the -80-mV prepulse, and this quantity was least-squares fitted to a Boltzman expression'' to estimate the potential of half-maximal inactivation and the slope factor.
Bath temperature during the patch clamp recording was controlled using a circular thermofoil heater 115 mm in diameter (MT-1; Narishige), with a 35-mm central opening. Temperature sensing was performed by means of a small insulated thermocouple situated no more than 5 mm from that cell from which recordings were being made. The overall stability of this system was +O.l"C from the set point.
Measurement of Anesthetic Concentrations in the Gas Phase and in the Bath Solution
The vaporizers for isoflurane and sevoflurane were calibrated using an infrared anesthetic gas monitor (5250 RGM; Datex-Ohmeda, Madison, W I ) . Concentrations of the anesthetic agents in bath solution samples were analyzed using a gas chromatograph (GC-17A; Shimadzu, Kyoto, Japan). The mean concentrations of isoflurane in the solution at 37°C: (1.0, 2.0, and 3.0% in the gas phase) were 0.26, 0.52, and 0.82 mM, respectively, whereas the mean concentrations of sevoflurane in the solution (1 .O, 2.0, and 3.0% in the gas phase) were 0.16, 0.35, and 0.54 m, respectively. Each concentration of the anesthetic had a close linear correlation with each concentration of the agent in the gas phase. There were no significant differences between the concentrations of these anes thetics in the perfusion chamber for patch clamp recording and those in the bath solution of a spectrometer, or between the concentrations of different temperatures of the bath solution in the range between 31 and 37°C (n = 4 , data not shown).
Materials
The following drugs and chemicals were used: p-hydroxybutyrate, cremophor EL (Sigma Chemical, St. Louis, MO), acetoxymethyl ester of fiira-2 (Dojindo Laboratories, Kumamoto, Japan), type I collagenase (Gibco Laboratories, Grand Island, NY), isoflurane (Ohio Medical, Madison, WI), and sevoflurane (Maruishi Pharmacoceutical, Osaka, Japan).
Statistical Analysis
Data are expressed as the mean -C SD. For the measurement of [Ca2+Ii and muscle tension, high-K+-induced sustained changes in [Ca2+Ii (indicated by R340, 380) and muscle tension at 37°C were used as references (100%). Changes in measured parameters with exposure to each anesthetic were compared at each point (concentrations or applied potential) using the paired twotailed t test. One-way analysis of variance for repeated measurements and the Fisher exact test were used to determine the concentration-dependent effects. In all comparisons, P < 0.05 was considered to be significant.
Results
Effects of Volatile Anesthetics or Changes in Temperature on Muscle Tension and (Ca"+ J i
At 37"C, the ratio R;140,3H,,, an indicator of [Ca2+Ii, was increased rapidly by high K+ (72.7 mM), with a concomitant contraction ( fig. 1). [Ca2+], and muscle tension reached their respective peaks within 10-50 s. With carbachol, [Ca2+Ii also increased rapidly to a concentration similar to that induced by high K+. The amount of muscle contraction with carbachol, however, was more than twice that induced by high K+, indicating that carbachol induces a greater contraction than does high K+ at a given [Ca2+Ii. Exposure to low temperature (34OC) significantly decreased high-K+ -induced muscle contraction and increase in [Ca2+Ii. Low temperature also decreased the carbachol-induced increase in [Ca2+],; however, it enhanced carbachol-induced muscle contraction. The effects of 3% isoflurane with a decrease in temperature (31°C) are shown in figure 2. Isoflurane significantly and similarly inhibited high-K+-induced Exposure to low temperature, however, significantly prevented the inhibitory effect of sevoflurane on carbachol-induced muscle contraction, and the increase in [Ca2+] caused by carbachol was inhibited significantly by exposure to low-temperature exposure at all concentrations of sevoflurane (n = 7; fig. 3B ). Similar effects of exposure to low temperature were seen with isoflurane (by 11-18% at 31"C, n = 6; data not shown).
Effects of Volatile Anesthetics or Changes in Temperature on I,, Currents through Voltagedependent Ca2+ Channels
Voltage-pulse protocols were performed in control solutions for more than 5 min to obtain a stable baseline value. Data from cells that showed unstable I,, amplitudes, less than 100 PA of peak La, or a more than 10% reduction in amplitude during the control recording period were discarded. Technically satisfactory data were obtained from 84 cells studied at the holding potential of -80 mV. In all cases, recordings were performed at two different temperatures (37 and 31°C) . At any given temperature, there was sufficient consistency in peak current amplitude and time course to justify the pooling of records according to temperature. At 37"C, I,, seen in dispersed canine tracheal smooth muscle cells during step depolarization from -80 mV peaked at approximately 10 ms and was inactivated with a time constant in the range between 70 and 100 ms ( fig. 4A ). As shown in a representative trace for depolarization from -80 to 10 mV ( fig. 4A ), the amplitude of I,, was clearly sensitive to temperature, and exposure to low Anesthetic concentrations (%) temperature (3 1 "C) inhibited the magnitude of Ica. Figure 4B shows the relation between peak I,, and applied potential before and after exposure to low temperature (3 1 "C). Low-temperature exposure significantly inhibited I, , at step potentials in the range between -10 and 40 mV and decreased peak I, , at 10 mV by approximately 18% (n = 7). There was no apparent shift in the voltage-dependence of I,,. We determined the dosedependence of the inhibition of peak I, , by each volatile anesthetic tested. Figure 5 shows the relations between the percentage of control peak I, , at 10 mV and the concentration of each anesthetic, isoflurane ( fig. 5A ) and sevoflurane ( fig. 5B ), in the gas phase. Both volatile anesthetics significantly inhibited peak I, , in a dosedependent manner (n = 7). Exposure to low tempera-
Anesthetic concentrations (%) ture significantly inhibited the I,, at all concentrations of these anesthetics (n = 7). The effects of the volatile anesthetics isoflurane and sevoflurane at equieffective inhibitory concentrations (2.0 and 3.0%, respectively) on the inactivation curve of I, , currents are summarized in figure 6 and table 1. Each of these anesthetics shifted the inactivation curve to a more negative potential (n = 7). Exposure to low temperature also significantly shifted the inactivation curve to a more negative potential (n = 7). The induced changes in the potential of half-maximal inactivation brought about both by these anesthetics and by the low temperature were statistically significant in each case. The slope factor was not changed by exposure to either the anesthetics or low temperature. 
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Discussion
Effects of Volatile Anesthetics or Changes in
Temperature on Muscle Tension and Lea2%
One of the major findings of our study is that in canine tracheal smooth muscle in vitro, exposure of the muscle to low temperature significantly decreased high-K+-induced muscle contraction and increase in (Ca2+] with an enhancement of the agonist-induced contraction of airway smooth m~s c l e . ' -~~'~-'~ The results of these studies suggested that the effect of direct exposure to low temperature on airway smooth muscle per se has some role in low-temperature-induced airway hyperresponsiveness in a clinical situation. Ishii and Shimo" and Freed and Stream,'' however, showed in in vivo studies that exposure of the airway to low temperature decreased the response to contractile agonists in guinea pigs and in dogs, respectively. These apparent discrepancies may result from differences in agonist types, concentrations, in vivo or in vitro studies, species, or the temperature gradients used in these studies.
Intracellular Ca2+ is the primary regulator of smooth muscle c~ntraction.~'~' [Ca2'], is regulated by influx of Ca2+ through cell membrane-associated Ca'+ channels and by release of Ca2+ from intracellular Ca' + stores, especially the sarcoplasmic r e t i c~l u m .~ lshii and Shimo3 reported that increased responsiveness of the rat airway smooth muscle to acetylcholine with lowered temperature might involve the enhancement of increase in [Ca2+],, resulting from the acceleration of Ca2+ release from the sarcoplasmic reticulum, inhibition of Ca'+ extrusion from the cell, or the inhibition of Caz+ reuptake by the sarcoplasmic reticulum. Release of Ca'+ from the sarcoplasmic reticulum is, however, important in initiation, not maintenance, of the muscle c o n t r a~t i o n ,~-~ and we found that the low temperature could enhance the agonist-induced muscle contractility with a decrease in [CaZ+li ( fig. 1) . Therefore, the change in [Ca'+Ii cannot be attributed to the low-temperature-induced contraction of airway smooth muscle shown in this study. Low temperature could increase Ca2+ sensitivity in a broad sense. Activation of muscarinic receptors also activates protein kinase C concomitant with an increase in [Ca'+li. Many in~estigators,~""'~ including us,' have shown that protein kinase C activation by muscarinic agonist sensitizes contractile elements to Ca2+ or activates a Cazf-independent mechanism in airway smooth muscles, because carbachol induces a much greater contraction than does high K+ at a given [Ca2+], ( fig. 1 ). Huang et aAZ5 reported that a potent exogenous protein kinase C activator, phorbol-12,13-diacetate, increased airway smooth muscle tone more at a lower temperature. Therefore, protein kinase C is thought to play a role in regulation of airway smooth muscle contractility at different temperatures. The role of protein kinase C activity in airway smooth muscle tone, however, is cont r o~e r s i a l .~~~'~ Investigations of this possibility, such as measurement of muscle tension in P-escin-permeabilized skinned fiber," must be conducted in the future. 
Effects of Volatile Anesthetics or Changes in
Limitations of This Study
There is a possibility that changes in temperature per se could have changed the affinity of fura-2 for Ca2+." We therefore confirmed the effect of temperature on R340,380, an indicator of [Ca2+],, in tracheal smooth muscle strips by the use of the skinned fiber technique," and we found that the R340,380 did not change within the temperature range tested (3 1-37°C ). There is another report suggesting that the affinity of a Ca2+ chelate compound such as EGTA could be changed by PH.~' Grynkiewicz et a1.,39 however, reported that the intensity of excitation of fura-2 by 500-nm light was not changed by pH excursion. We therefore believe that the measurement of [Ca2+Ii by the use of fura-2 in this study was reliable.
Another uncertainty is the variation in solubilities of volatile anesthetics at different temperatures4' We confirmed that the concentrations of the volatile anesthetics in the bath solution were indistinguishable at the different temperatures tested in this study. That is why the replacement of the bath solution in this study was accomplished by changing the inflow perfusate to one that had been bubbled vigorously with each anesthetic at 37"C, and the temperature of the solution was changed during passage through the tube to the bath. We still do not know whether the solubilities of volatile anesthetics in oil or fat (cell membrane) vary at different temperatures. There is a possibility that the change in the solubility of volatile anesthetics in cell membranes at different temperatures plays a role in the low-temperatureinduced suppression of VDCC activity.
Exposure to low temperature significantly decreased both high-K+ -induced muscle contraction and increase in 
